The following is a summary of “Endovascular Thrombectomy for Extracranial Internal Carotid Artery Occlusions With Large ...

In any case, there was no mortality signal associated with alteplase administered up to 24 hours after a stroke in HOPE.

Revalesio updates new analyses from phase 2 RESCUE clinical study of RNS60 in patients with acute ischemic stroke: Tacoma, Washington Friday, February 7, 2025, 18:00 Hrs [IST] Rev ...

Three trials showed no improvement in functional outcomes, and the potential for harm, versus medical therapy alone.

treatment with REC-994 400 mg showed promising signals in both MRI-based lesion volume reduction and functional outcome as ...

In an editorial, J. Mocco, MD, of Mount Sinai Health System in New York City, characterized the DISTAL and ESCAPE-MeVO ...

Met primary endpoint of safety and tolerability in CCM patients with no treatment-related discontinuations or Grade 3 adverse eventsIn comparison to placebo, treatment with REC-994 400 mg showed promi ...

University of Cincinnati experts will present research at the International Stroke Conference 2025 in Los Angeles.

Functional recovery at 90 days was lower in the balloon-guided catheter group versus the conventional catheter group. 2.

In patients with high comorbidity burden that receive EVT for MCA medium-vessel occlusion there are worse clinical outcomes.

The modified Rankin Scale (mRS) is a commonly used functional outcome assessment in stroke clinical trials and has become an essential metric for stroke research. However, the mRS is not routinely ...